Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:515-525
Published online before print July 23, 2007, doi: 10.1161/CIRCULATIONAHA.107.689984
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/5/515    most recent
CIRCULATIONAHA.107.689984v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knöll, R.
Right arrow Articles by Bakkers, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knöll, R.
Right arrow Articles by Bakkers, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Physiological and pathological control of gene expression

(Circulation. 2007;116:515-525.)
© 2007 American Heart Association, Inc.


Heart Failure

Laminin-{alpha}4 and Integrin-Linked Kinase Mutations Cause Human Cardiomyopathy Via Simultaneous Defects in Cardiomyocytes and Endothelial Cells

Ralph Knöll, MD, PhD*; Ruben Postel, MSc*; Jianming Wang, PhD; Ralph Krätzner, PhD; Gerrit Hennecke, PhD; Andrei M. Vacaru, MSc; Padmanabhan Vakeel, PhD; Cornelia Schubert, MD; Kenton Murthy; Brinda K. Rana, PhD; Dieter Kube, MD; Gudrun Knöll; Katrin Schäfer, MD; Takeharu Hayashi, MD, PhD; Torbjorn Holm, MD; Akinori Kimura, MD, PhD; Nicholas Schork, MD, PhD; Mohammad Reza Toliat, PhD; Peter Nürnberg, MD, PhD; Heinz-Peter Schultheiss, MD; Wolfgang Schaper, MD, PhD; Jutta Schaper, MD, PhD; Erik Bos, MSc; Jeroen Den Hertog, PhD; Fredericus J.M. van Eeden, PhD; Peter J. Peters, PhD; Gerd Hasenfuss, MD, PhD; Kenneth R. Chien, MD, PhD; Jeroen Bakkers, PhD

From the Institute of Molecular Medicine (R. Knöll, J.W., T. Holm, K.R.C.), Department of Medicine (K.R.C.), and Department of Psychiatry (K.M., B.K.R., N.S.), University of California at San Diego, La Jolla, Calif; Harvard Medical School (K.R.C.), Boston, Mass; Max-Planck Institute (W.S., J.S.), Bad Nauheim, Germany; Department of Molecular Pathogenesis (T. Hayashi, A.K.), Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; Heart Center (R. Knöll, P.V., G.K., K.S., G. Hasenfuss), Hematology and Oncology (D.K.), Molecular Pharmacology and Institute of Molecular Genetics (R. Krätzner, G. Hennecke) and Abteilung Humangenetik (C.S.), University Hospital Göttingen, Göttingen, Germany; Universitätsklinikum Benjamin Franklin (H.-P.S.), Medizinische Klinik II, Freie Universität Berlin, Berlin, Germany; Cologne Center for Genomics and Institute for Genetics (M.R.T., P.N.), University of Cologne, Cologne, Germany; Hubrecht Laboratory (R.P., A.M.V., F.J.M.v.E., J.B.), Utrecht, the Netherlands; Interuniversity Cardiology Institute for the Netherlands (R.P., J.B.), Utrecht, the Netherlands; and Netherlands Cancer Institute (E.B., P.J.P.), Amsterdam, the Netherlands. Dr van Eeden is presently affiliated with the Department of Biomedical Science, Sheffield University, Sheffield, UK.

Correspondence to Ralph H. Knöll, MD, PhD, Professor of Cardiovascular Molecular Genetics, Head of Cardiovascular Molecular Genetics, Robert Koch Straße 40, Georg August University Göttingen, Germany (e-mail rknoell{at}med.uni-goettingen.de); or Jeroen Bakkers, PhD, Cardiac Development and Genetics Group, Hubrecht Laboratory, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands (e-mail j.bakkers@niob.knaw.nl).

Received January 15, 2007; accepted May 29, 2007.

Background— Extracellular matrix proteins, such as laminins, and endothelial cells are known to influence cardiomyocyte performance; however, the underlying molecular mechanisms remain poorly understood.

Methods and Results— We used a forward genetic screen in zebrafish to identify novel genes required for myocardial function and were able to identify the lost-contact (loc) mutant, which encodes a nonsense mutation in the integrin-linked kinase (ilk) gene. This loc/ilk mutant is associated with a severe defect in cardiomyocytes and endothelial cells that leads to severe myocardial dysfunction. Additional experiments revealed the epistatic regulation between laminin-{alpha}4 (Lama4), integrin, and Ilk, which led us to screen for mutations in the human ILK and LAMA4 genes in patients with severe dilated cardiomyopathy. We identified 2 novel amino acid residue–altering mutations (2828C>T [Pro943Leu] and 3217C>T [Arg1073X]) in the integrin-interacting domain of the LAMA4 gene and 1 mutation (785C>T [Ala262Val]) in the ILK gene. Biacore quantitative protein/protein interaction data, which have been used to determine the equilibrium dissociation constants, point to the loss of integrin-binding capacity in case of the Pro943Leu (Kd=5±3 µmol/L) and Arg1073X LAMA4 (Kd=1±0.2 µmol/L) mutants compared with the wild-type LAMA4 protein (Kd=440±20 nmol/L). Additional functional data point to the loss of endothelial cells in affected patients as a direct consequence of the mutant genes, which ultimately leads to heart failure.

Conclusions— This is the first report on mutations in the laminin, integrin, and ILK system in human cardiomyopathy, which has consequences for endothelial cells as well as for cardiomyocytes, thus providing a new genetic basis for dilated cardiomyopathy in humans.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
BloodHome page
S. Honda, H. Shirotani-Ikejima, S. Tadokoro, Y. Maeda, T. Kinoshita, Y. Tomiyama, and T. Miyata
Integrin-linked kinase associated with integrin activation
Blood, May 21, 2009; 113(21): 5304 - 5313.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
T. Dahme, H. A. Katus, and W. Rottbauer
Fishing for the genetic basis of cardiovascular disease
Dis. Model. Mech., January 1, 2009; 2(1-2): 18 - 22.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Hammerschmidt and D. Wedlich
Regulated adhesion as a driving force of gastrulation movements
Development, November 15, 2008; 135(22): 3625 - 3641.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. C. McDonald, A. B. Fielding, and S. Dedhar
Integrin-linked kinase - essential roles in physiology and cancer biology
J. Cell Sci., October 1, 2008; 121(19): 3121 - 3132.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Akhyari, H. Kamiya, A. Haverich, M. Karck, and A. Lichtenberg
Myocardial tissue engineering: the extracellular matrix.
Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 229 - 241.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. J. Hatcher and C. T. Basson
Disrupted Intercalated Discs: Is Kindlin-2 Required?
Circ. Res., February 29, 2008; 102(4): 392 - 394.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. J. Dowling, E. Gibbs, M. Russell, D. Goldman, J. Minarcik, J. A. Golden, and E. L. Feldman
Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and Function
Circ. Res., February 29, 2008; 102(4): 423 - 431.
[Abstract] [Full Text] [PDF]